FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Testosterone 2.5mg/24hours transdermal patches VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 5mg/24hours transdermal patches VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone propionate 100mg/2ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tramadol 75mg modified-release tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium fusidate 500mg powder and solvent for solution for infusion vials VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium hyaluronate 8.5mg/0.85ml solution for injection pre-filled syringes VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Squill opiate linctus paediatric VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Propofol 1g/100ml emulsion for infusion vials VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Propofol 1g/50ml emulsion for infusion vials VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Propofol 500mg/50ml emulsion for infusion vials VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Selegiline 10mg/5ml oral solution VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Adalimumab 40mg/0.8ml solution for injection pre-filled disposable devices VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Adalimumab 40mg/0.8ml solution for injection pre-filled syringes VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Adalimumab 40mg/0.8ml solution for injection pre-filled disposable devices 2 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Humira 40mg/0.8ml solution for injection pre-filled syringes (Abbott Laboratories Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Adalimumab 40mg/0.8ml solution for injection pre-filled syringes 2 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Humira 40mg/0.8ml solution for injection pre-filled pens (AbbVie Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amgevita 40mg/0.8ml solution for injection pre-filled syringes (Amgen Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amgevita 40mg/0.8ml solution for injection pre-filled pens (Amgen Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Humira 40mg/0.8ml solution for injection pre-filled syringes (Abbott Laboratories Ltd) 2 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Humira 40mg/0.8ml solution for injection pre-filled pens (AbbVie Ltd) 2 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amgevita 40mg/0.8ml solution for injection pre-filled syringes (Amgen Ltd) 2 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amgevita 40mg/0.8ml solution for injection pre-filled pens (Amgen Ltd) 2 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Phentolamine 10mg/1ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Potassium chloride 0.15% (potassium 10mmol/500ml) / Glucose 5% infusion 500ml bags VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Procyclidine 10mg/2ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pericyazine 10mg/5ml oral solution VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nalbuphine 20mg/2ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Naloxone 40micrograms/2ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nicotinic acid 500mg modified-release tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nisoldipine 10mg modified-release tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nisoldipine 20mg modified-release tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nisoldipine 30mg modified-release tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Norethisterone 200mg/1ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Leuprorelin 3.75mg powder and solvent for suspension for injection vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Levofloxacin 500mg/100ml solution for infusion vials VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metaraminol 10mg/1ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hypromellose 0.32% eye drops 0.5ml unit dose preservative free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Idarubicin 10mg/10ml solution for injection vials VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Idarubicin 5mg/5ml solution for injection vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Guanethidine 10mg/1ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 5mg/1ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heparin calcium 5,000units/0.2ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 1,000units/1ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 25,000units/1ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 25,000units/5ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 5,000units/0.2ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 5,000units/1ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hexetidine 0.1% mouthwash sugar free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
High Purity Factor VIII 250unit powder and solvent for solution for injection vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Hydroxyzine 10mg/5ml oral solution VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fluphenazine decanoate 100mg/1ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fluphenazine decanoate 25mg/1ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fluphenazine decanoate 50mg/0.5ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fluphenazine decanoate 50mg/2ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Orthovisc 30mg/2ml injection pre-filled syringes VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Gentamicin 20mg/2ml solution for injection vials VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxapram 100mg/5ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clomethiazole 157.5mg/5ml oral solution sugar free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clomipramine 75mg modified-release tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clotrimazole 1% powder VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Coal tar solution 10% cream VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
CovaWound Silicone Foam Border dressing 15cm x 20cm (Covalon Technologies (Europe) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution (Morningside Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Medreich Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
CovaWound Silicone Foam Border dressing 15cm x 20cm (Covalon Technologies (Europe) Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
CovaWound Silicone Foam Border dressing 15cm x 20cm (Covalon Technologies (Europe) Ltd) 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution (Morningside Healthcare Ltd) 120 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pyrazinamide 500mg tablets (Morningside Healthcare Ltd) 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Berocca effervescent tablets blackcurrant (Bayer Plc) 45 tablet 3 x 15 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Berocca effervescent tablets mango (Bayer Plc) 45 tablet 3 x 15 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Berocca effervescent tablets mixed berries (Bayer Plc) 45 tablet 3 x 15 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Noristerat 200mg/1ml solution for injection ampoules (Waymade Healthcare Plc) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Noristerat 200mg/1ml solution for injection ampoules (Schering Health Care Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Norethisterone 200mg/1ml solution for injection ampoules 1 ampoule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Noristerat 200mg/1ml solution for injection ampoules (Schering Health Care Ltd) 1 ampoule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Noristerat 200mg/1ml solution for injection ampoules (Waymade Healthcare Plc) 1 ampoule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Anafranil SR 75mg tablets (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Anafranil SR 75mg tablets (Necessity Supplies Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Anafranil SR 75mg tablets (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Anafranil SR 75mg tablets (Doncaster Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clomipramine 75mg modified-release tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clomipramine 75mg modified-release tablets (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Anafranil SR 75mg tablets (PI) (Waymade Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clomipramine 75mg modified-release tablets (Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Anafranil SR 75mg tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clomipramine 75mg modified-release tablets 20 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Anafranil SR 75mg tablets (Lexon (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Anafranil SR 75mg tablets (PI) (Dowelhurst Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Anafranil SR 75mg tablets (PI) (Dowelhurst Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Anafranil SR 75mg tablets (Stephar (U.K.) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clomipramine 75mg modified-release tablets 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clomipramine 75mg modified-release tablets 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Anafranil SR 75mg tablets (Sigma Pharmaceuticals Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Anafranil SR 75mg tablets (Sigma Pharmaceuticals Plc) 20 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Anafranil SR 75mg tablets (Sigma Pharmaceuticals Plc) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Anafranil SR 75mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Anafranil SR 75mg tablets (Lexon (UK) Ltd) 20 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Anafranil SR 75mg tablets (Necessity Supplies Ltd) 20 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 81 of 86 Next End

This concept is not in any reference sets

Back to Start